Integrating traditional medicine into modern inflammatory diseases care: Multitargeting by rhus verniciflua stokes

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Kim, Ji Hye ^a   Shin, Yong Cheol ^a   Ko, Seong Gyu ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUTEIN; CHALCONE DERIVATIVE; FISETIN; FLAVONOID; FLAVONOL DERIVATIVE; HERBACEOUS AGENT; KAEMPFEROL; PHENOL DERIVATIVE; QUERCETIN; TANNIN DERIVATIVE; URUSHIOL; ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CARCINOGENESIS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CYTOTOXICITY; DEGENERATIVE DISEASE; DIABETES MELLITUS; HEMATOLOGIC DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION; INFLAMMATORY DISEASE; LIVER DISEASE; LIVER PROTECTION; MACROPHAGE; NEUROPROTECTION; NONHUMAN; OXIDATION; POISON IVY; REVIEW; RHUS VERNICIFLUA STOKES; SIGNAL TRANSDUCTION; STOMACH DISEASE; TRADITIONAL MEDICINE; ANIMAL; CHEMISTRY; INFLAMMATION; PROCEDURES; TOXICODENDRON;

ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; MEDICINE, TRADITIONAL; PLANT EXTRACTS; RHUS;

EID: 84903639465     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/154561     Document Type: Review

References (113)

1. Aggarwal B. B., Gupta S. C., Park B., Yadav V. R., Kim J. H., Chronic diseases caused by chronic inflammation require chronic treatment: the anti-inflammatory lifestyle. Inflammation, Lifestyle and Chronic Diseases: The Silent Link 2011 Chapter 14 CRC Press
2. Aggarwal B. B., Ichikawa H., Garodia P., Weerasinghe P., Sethi G., Bhatt I. D., Pandey M. K., Shishodia S., Nair M. G., From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opinion on Therapeutic Targets 2006 10 1 87 118 2-s2.0-33144487679 10.1517/14728222.10.1.87 (Pubitemid 43263269)
3. Hsiao W. L. W., Liu L., The role of traditional Chinese herbal medicines in cancer therapy-from TCM theory to mechanistic insights. Planta Medica 2010 76 11 1118 1131 2-s2.0-77955058763 10.1055/s-0030-1250186
4. Network U. A. R. S. G. R. I., Toxicodendron vernicifluum information from NPGS/GRIN. U. S. D. o. Agriculture, 2013
5. Yoo H. T., Roh J. R., Compendium of Prescriptions From the Countryside (Hyangyakjipseongbang) 1977 1433 Seoul, Republic of Korea Hangrimchulpansa
6. Suk K. T., Baik S. K., Kim H. S., Park S. M., Paeng K. J., Uh Y., Jang I. H., Cho M. Y., Choi E. H., Kim M. J., Ham Y. L., Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua stokes) on Helicobacter pylori. Helicobacter 2011 16 6 434 443 2-s2.0-80755180919 10.1111/j.1523-5378.2011.00864.x
7. Kitts D. D., Lim K.-T., Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua stokes (RVS). Journal of Toxicology and Environmental Health A 2001 64 4 357 371 2-s2.0-0035955459 10.1080/152873901316981330 (Pubitemid 32989448)
8. Lee J.-C., Kim J., Jang Y.-S., Ethanol-eluted extract of Rhus verniciflua stokes inhibits cell growth and induces apoptosis in human lymphoma cells. Journal of Biochemistry and Molecular Biology 2003 36 4 337 343 2-s2.0-0041328341 (Pubitemid 37100922)
9. Jang H.-S., Kook S.-H., Son Y.-O., Kim J.-G., Jeon Y.-M., Jang Y.-S., Choi K.-C., Kim J., Han S.-K., Lee K.-Y., Park B.-K., Cho N.-P., Lee J.-C., Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochimica et Biophysica Acta-General Subjects 2005 1726 3 309 316 2-s2.0-27944448516 10.1016/j.bbagen.2005.08.010 (Pubitemid 41668540)
10. Son Y.-O., Lee K.-Y., Lee J.-C., Jang H.-S., Kim J.-G., Jeon Y.-M., Jang Y.-S., Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicology Letters 2005 155 1 115 125 2-s2.0-10044290769 10.1016/j.toxlet.2004. 09.003 (Pubitemid 39600743)
11. Kim J. H., Kim H.-P., Jung C.-H., Hong M. H., Hong M.-C., Bae H.-S., Lee S.-D., Park S.-Y., Park J.-H., Ko S.-G., Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua Stokes in AGS gastric cancer cells. International Journal of Molecular Medicine 2006 18 1 201 208 2-s2.0-33748173832
12. Kook S.-H., Son Y.-O., Chung S.-W., Lee S.-A., Kim J.-G., Jeon Y.-M., Lee J.-C., Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis 2007 12 7 1289 1298 2-s2.0-34249987420 10.1007/s10495-007-0056-x (Pubitemid 46890386)
13. Kim J. H., Go H. Y., Jin D. H., Kim H.-P., Hong M. H., Chung W.-Y., Park J.-H., Jang J. B., Jung H., Shin Y. C., Kim S.-H., Ko S.-G., Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Letters 2008 265 2 197 205 2-s2.0-43949116902 10.1016/j.canlet. 2008.02.039
14. Kim J. H., Jung C. H., Jang B.-H., Go H. Y., Park J.-H., Choi Y.-K., Hong S. I., Shin Y. C., Ko S.-G., Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua stokes. The American Journal of Chinese Medicine 2009 37 3 609 620 2-s2.0-68149125240 10.1142/S0192415X09007090
15. Lee J.-C., Lee K.-Y., Kim J., Na C.-S., Jung N.-C., Chung G.-H., Jang Y.-S., Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food and Chemical Toxicology 2004 42 9 1383 1388 2-s2.0-3042565160 10.1016/j.fct.2004.03.012 (Pubitemid 38844855)
16. Samoszuk M., Tan J., Chorn G., The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complementary and Alternative Medicine 2005 5, article 5 2-s2.0-25444495234 10.1186/1472-6882-5-5 (Pubitemid 41364089)
17. Choi H. S., Seo H. S., Kim S. R., Choi Y. K., Jang B. H., Shin Y. C., Ko S. G., Antiinflammatory and antiproliferative effects of Rhus verniciflua Stokes in RAW264. 7 cells. Molecular Medicine Reports 2014 9 5 1569 1574 10.3892/mmr.2014.2033
18. Jung C. H., Kim J. H., Hong M. H., Seog H. M., Oh S. H., Lee P. J., Kim G. J., Kim H. M., Um J. Y., Ko S.-G., Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF- B and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. Journal of Ethnopharmacology 2007 110 3 490 497 2-s2.0-33847698484 10.1016/j.jep.2006.10. 013 (Pubitemid 46386364)
19. Oh P.-S., Lee S.-J., Lim K.-T., Glycoprotein isolated from Rhus verniciflua STOKES inhibits inflammation-related protein and nitric oxide production in LPS-stimulated RAW 264.7 cells. Biological and Pharmaceutical Bulletin 2007 30 1 111 116 2-s2.0-33846106891 10.1248/bpb.30.111 (Pubitemid 46066329)
20. Hong M. H., Kim J.-H., Lee S. Y., Go H. Y., Kim J. H., Shin Y.-C., Kim S.-H., Ko S.-G., Early antiallergic inflammatory effects of Rhus verniciflua stokes on human mast cells. Phytotherapy Research 2010 24 2 288 294 2-s2.0-75849118035 10.1002/ptr.2941
21. Lee D.-S., Jeong G.-S., Li B., Park H., Kim Y.-C., Anti-inflammatory effects of sulfuretin from Rhus verniciflua Stokes via the induction of heme oxygenase-1 expression in murine macrophages. International Immunopharmacology 2010 10 8 850 858 2-s2.0-77954955356 10.1016/j.intimp.2010.04.019
22. Jung C. H., Kim J.-H., Kim J. H., Chung J. H., Choi H.-S., Seo J. B., Shin Y.-C., Kim S.-H., Ko S.-G., Anti-inflammatory effect of Rhus verniviflua Stokes by suppression of iNOS-mediated Akt and ERK pathways: in-vitro and in-vivo studies. Journal of Pharmacy and Pharmacology 2011 63 5 679 687 2-s2.0-79954689625 10.1111/j.2042-7158.2011.01251.x
23. Lee J.-D., Huh J.-E., Jeon G., Yang H.-R., Woo H.-S., Choi D.-Y., Park D.-S., Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. International Immunopharmacology 2009 9 3 268 276 2-s2.0-60549095283 10.1016/j.intimp.2008.11.005
24. Park D. K., Lee Y. G., Park H.-J., Extract of Rhus verniciflua bark suppresses 2,4-dinitrofluorobenzene- induced allergic contact dermatitis. Evidence-Based Complementary and Alternative Medicine 2013 2013 11 2-s2.0-84877934563 10.1155/2013/879696 879696
25. Lee J.-C., Lim K.-T., Jang Y.-S., Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochimica et Biophysica Acta-General Subjects 2002 1570 3 181 191 2-s2.0-0037089441 10.1016/S0304-4165(02)00196-4 (Pubitemid 34518599)
26. Lim K.-T., Hu C., Kitts D. D., Antioxidant activity of a Rhus verniciflua Stokes ethanol extract. Food and Chemical Toxicology 2001 39 3 229 237 2-s2.0-0035081363 10.1016/S0278-6915(00)00135-6 (Pubitemid 32244130)
27. Ko J.-H., Lee S.-J., Lim K.-T., 36 kDa Glycoprotein isolated from Rhus verniciflua Stokes fruit has a protective activity to glucose/glucose oxidase-induced apoptosis in NIH/3T3 cells. Toxicology in Vitro 2005 19 3 353 363 2-s2.0-13844271495 10.1016/j.tiv.2004.10.006 (Pubitemid 40248752)
28. 2-induced cytotoxicity in macrophage RAW 264.7 cell lines. Biological and Pharmaceutical Bulletin 2006 29 8 1603 1607 2-s2.0-33746721513 10.1248/bpb.29.1603 (Pubitemid 44166359)
29. Lee J.-H., Lee H.-J., Lee H.-J., Choi W.-C., Yoon S.-W., Ko S.-G., Ahn K. S., Choi S.-H., Ahn K.-S., Lieske J. C., Kim S.-H., Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice. Phytomedicine 2009 16 2-3 188 197 2-s2.0-59649119482 10.1016/j.phymed.2008.10.009
30. Liu C. S., Nam T. G., Han M. W., Ahn S. M., Choi H. S., Kim T. Y., Chun O. K., Koo S. I., Kim D. O., Protective effect of detoxified Rhus verniciflua stokes on human keratinocytes and dermal fibroblasts against oxidative stress and identification of the bioactive phenolics. Bioscience, Biotechnology, and Biochemistry 2013 77 8 1682 1688
31. Kang S. Y., Kang J.-Y., Oh M.-J., Antiviral activities of flavonoids isolated from the bark of Rhus verniciflua stokes against fish pathogenic viruses in vitro. Journal of Microbiology 2012 50 2 293 300 2-s2.0-84860355352 10.1007/s12275-012-2068-7
32. Cho N., Choi J. H., Yang H., Jeong E. J., Lee K. Y., Kim Y. C., Sung S. H., Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines. Food and Chemical Toxicology 2012 50 6 1940 1945 2-s2.0-84860132077 10.1016/j.fct.2012. 03.052
33. Kim S., Park S.-E., Sapkota K., Kim M.-K., Kim S.-J., Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease. Journal of Pharmacy and Pharmacology 2011 63 10 1358 1367 2-s2.0-80052591460 10.1111/j.2042-7158.2011.01342.x
34. Byung C. P., Yong S. L., Park H.-J., Kwak M.-K., Bong K. Y., Joo Y. K., Kim J.-A., Protective effects of fustin, a flavonoid from Rhus verniciflua stokes, on 6-hydroxydopamine-induced neuronal cell death. Experimental and Molecular Medicine 2007 39 3 316 326 2-s2.0-34447128130 (Pubitemid 47037622)
35. Sapkota K., Kim S., Kim M.-K., Kim S.-J., A detoxified extract of Rhus verniciflua stokes upregulated the expression of BDNF and GDNF in the rat brain and the human dopaminergic cell line SH-SY5Y. Bioscience, Biotechnology and Biochemistry 2010 74 10 1997 2004 2-s2.0-78049363468 10.1271/bbb.100165
36. Sapkota K., Kim S., Park S.-E., Kim S.-J., Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y. Cellular and Molecular Neurobiology 2011 31 2 213 223 2-s2.0-79959741268 10.1007/s10571-010-9609-6
37. Jeon W. K., Lee J. H., Kim H. K., Lee A. Y., Lee S. O., Kim Y. S., Ryu S. Y., Kim S. Y., Lee Y. J., Ko B. S., Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes. Journal of Ethnopharmacology 2006 106 1 62 69 2-s2.0-33646671949 10.1016/j.jep.2005.12.015 (Pubitemid 43732486)
38. Song D.-G., Lee J. Y., Lee E. H., Jung S. H., Nho C. W., Cha K. H., Koo S. Y., Pan C.-H., Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10. BMB Reports 2010 43 4 268 272 2-s2.0-77953528179
39. Lee J., Lim K.-T., Plant-originated glycoprotein (36kDa) suppresses interleukin-4 and-10 in bisphenol Astimulated primary cultured mouse lymphocytes. Drug and Chemical Toxicology 2010 33 4 421 429 2-s2.0-77956147456 10.3109/01480541003739229
40. Gupta S. C., Kim J. H., Prasad S., Aggarwal B. B., Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews 2010 29 3 405 434 2-s2.0-77957592789 10.1007/s10555-010-9235- 2
41. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
42. Gupta S. C., Kim J. H., Prasad S., Aggarwal B. B., Chronic inflammation and cancer: a matter of lifestyle. Chronic Inflammation: Molecular Pathophysiology, Nutritional and Therapeutic Interventions 2012 Chapter 12 CRC Press
43. Hansen I., Klimek L., Mösges R., Hörmann K., Mediators of inflammation in the early and the late phase of allergic rhinitis. Current Opinion in Allergy and Clinical Immunology 2004 4 3 159 163 2-s2.0-2542490249 10.1097/00130832-200406000-00004 (Pubitemid 38685515)
44. Jung C. H., Zhou S., Ding G. X., Kim J. H., Hong M. H., Shin Y.-C., Kim G. J., Ko S.-G., Antihyperglycemic activity of herb extracts on streptozotocin-induced diabetic rats. Bioscience, Biotechnology and Biochemistry 2006 70 10 2556 2559 2-s2.0-33750436228 10.1271/bbb.60238 (Pubitemid 44656429)
45. Oh P.-S., Lee S.-J., Lim K.-T., Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in triton WR-1339-induced hyperlipidemic mice. Bioscience, Biotechnology and Biochemistry 2006 70 2 447 456 2-s2.0-33344469139 10.1271/bbb.70.447 (Pubitemid 43289427)
46. Choi K.-C., Chung W.-T., Kwon J.-K., Jang Y.-S., Yu J.-Y., Park S.-M., Lee J.-C., Chemoprevention of a flavonoid fraction from Rhus verniciflua Stokes on aflatoxin B1-induced hepatic damage in mice. Journal of Applied Toxicology 2011 31 2 150 156 2-s2.0-79951997945 10.1002/jat.1575
47. Ko J.-H., Lee S.-J., Lim K.-T., Rhus verniciflua Stokes glycoprotein (36 kDa) has protective activity on carbon tetrachloride-induced liver injury in mice. Environmental Toxicology and Pharmacology 2006 22 1 8 14 2-s2.0-33646891309 10.1016/j.etap.2005.10.005 (Pubitemid 43786342)
48. Lim K.-T., Lee S.-J., Heo K.-S., Lim K., Effects of glycoprotein isolated from Rhus verniciflua stokes on TPA-induced apoptosis and production of cytokines in cultured mouse primary splenocytes. Toxicology Letters 2003 145 3 261 271 2-s2.0-0142247422 10.1016/S0378-4274(03)00304-7 (Pubitemid 37324611)
49. Lee S. H., Nan J.-X., Zhao Y. Z., Woo S. W., Park E.-J., Kang T.-H., Seo G. S., Kim Y.-C., Sohn D. H., The chalcone butein from Rhus verniciflua shows antifibrogenic activity. Planta Medica 2003 69 11 990 994 2-s2.0-0347320511 10.1055/s-2003-45143 (Pubitemid 38064686)
50. Lee S.-H., Choi W.-C., Yoon S.-W., Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience. Integrative Cancer Therapies 2009 8 2 148 152 2-s2.0-68949142782 10.1177/1534735409336438
51. Lee S.-H., Choi W.-C., Kim K.-S., Park J.-W., Lee S.-H., Yoon S.-W., Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua stokes extract. Journal of Alternative and Complementary Medicine 2010 16 4 497 500 2-s2.0-77951961628 10.1089/acm.2008.0237
52. Kim H. R., Kim K. S., Jung H. S., Choi W. C., Eo W. K., Cheon S. H., A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua stokes extract. Integrative Cancer Therapies 2010 9 1 100 104 2-s2.0-77953947348 10.1177/1534735409359772
53. Lee S. K., Jung H. S., Eo W. K., Lee S. Y., Kim S. H., Shim B. S., Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases. Annals of Oncology 2010 21 6 1383 1385 2-s2.0-77954152001 10.1093/annonc/mdq154
54. Lee S., Kim K., Jung H., Lee S., Cheon S., Kim S., Eo W., Choi W., Efficacy and safety of standardized allergen-removed Rhus verniciflua Stokes extract in patients with advanced or metastatic pancreatic cancer: a Korean single-center experience. Oncology 2012 81 5-6 312 318 2-s2.0-83455230808 10.1159/000334695
55. Lee S.-H., Kim K.-S., Choi W.-C., Yoon S.-W., Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua stokes extract: a case study. Explore: The Journal of Science and Healing 2009 5 4 242 244 2-s2.0-67650245475 10.1016/j.explore. 2009.04.001
56. Lee J., Chae J., Lee S., Kim K., Eo W., Kim S., Choi W., Cheon S. H., The efficacy and safety of standardized allergen-removed Rhus verniciflua extract as maintenance therapy after first-line chemotherapy in patients with advanced non-small cell lung cancer. The American Journal of Chinese Medicine 2013 41 4 773 787 2-s2.0-84881153586 10.1142/S0192415X13500523
57. Lee E. H., Song D.-G., Lee J. Y., Pan C.-H., Um B. H., Jung S. H., Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biological and Pharmaceutical Bulletin 2008 31 8 1626 1630 2-s2.0-48849111676 10.1248/bpb.31.1626
58. Jeong G.-S., Lee D.-S., Song M.-Y., Park B.-H., Kang D.-G., Lee H.-S., Kwon K.-B., Kim Y.-C., Butein from Rhus verniciflua protects pancreatic β cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation. Biological and Pharmaceutical Bulletin 2011 34 1 97 102 2-s2.0-78951485178 10.1248/bpb.34.97
59. Khan N., Adhami V. M., Afaq F., Mukhtar H., Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo. Antioxidants and Redox Signaling 2012 16 11 1195 1204 2-s2.0-84859860480 10.1089/ars.2011.4162
60. Lu M., Wang S., Han X., Lv D., Butein inhibits NF- B activation and reduces infiltration of inflammatory cells and apoptosis after spinal cord injury in rats. Neuroscience Letters 2013 542 87 91 2-s2.0-84876727874 10.1016/j.neulet.2013.03.004
61. Gábor M., Eperjessy E., Antibacterial effect of fisetin and fisetinidin. Nature 1966 212 5067, article 1273 2-s2.0-36949043890 10.1038/2121273a0
62. Schwartz A. G., Rate W. R., Inhibition of aflatoxin B1-induced cytotoxicity and binding to DNA in cultured rat liver cells by naturally occurring flavones. Journal of Environmental Pathology and Toxicology 1979 2 4 1021 1028 2-s2.0-0018654570 (Pubitemid 9246365)
63. Middleton E. Jr., Drzewiecki G., Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochemical Pharmacology 1984 33 21 3333 3338 2-s2.0-0021689737 10.1016/0006-2952(84)90102-3 (Pubitemid 15203615)
64. Nakadate T., Yamamoto S., Aizu E., Kato R., Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds. Gann, The Japanese Journal of Cancer Research 1984 75 3 214 222 2-s2.0-0021274213 (Pubitemid 14107229)
65. Ferriola P. C., Cody V., Middleton E. Jr., Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochemical Pharmacology 1989 38 10 1617 1624 2-s2.0-0024550507 (Pubitemid 19120080)
66. '-nitro-N- nitrosoguanidine. Carcinogenesis 1989 10 10 1953 1955 2-s2.0-0024366081 (Pubitemid 19244876)
67. Yamashita Y., Kawada S.-Z., Nakano H., Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochemical Pharmacology 1990 39 4 737 744 2-s2.0-0025189757 10.1016/0006-2952(90)90153-C (Pubitemid 20055769)
68. Tzeng S.-H., Ko W.-C., Ko F.-N., Teng C.-M., Inhibition of platelet aggregation by some flavonoids. Thrombosis Research 1991 64 1 91 100 2-s2.0-0025941984
69. Soliman K. F. A., Mazzio E. A., In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proceedings of the Society for Experimental Biology and Medicine 1998 218 4 390 397 2-s2.0-0031855756
70. Park J. B., Flavonoids are potential inhibitors of glucose uptake in U937 cells. Biochemical and Biophysical Research Communications 1999 260 2 568 574 2-s2.0-0033526848 10.1006/bbrc.1999.0890 (Pubitemid 29352102)
71. Joussen A. M., Rohrschneider K., Reichling J., Kirchhof B., Kruse F. E., Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids. Experimental Eye Research 2000 71 5 483 487 2-s2.0-0033711459 10.1006/exer.2000.0900
72. Zhang M., Zhang J.-P., Ji H.-T., Wang J.-S., Qian D.-H., Effect of six flavonoids on proliferation of hepatic stellate cells in vitro. Acta Pharmacologica Sinica 2000 21 3 253 256 2-s2.0-0034063548 (Pubitemid 30160987)
73. Chen Y.-C., Shen S.-C., Lee W.-R., Lin H.-Y., Ko C.-H., Shih C.-M., Yang L.-L., Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Archives of Toxicology 2002 76 5-6 351 359 2-s2.0-0036016874 10.1007/s00204-002-0346-6 (Pubitemid 34639530)
74. Hirano T., Higa S., Arimitsu J., Naka T., Shima Y., Ohshima S., Fujimoto M., Yamadori T., Kawase I., Tanaka T., Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. International Archives of Allergy and Immunology 2004 134 2 135 140 2-s2.0-2642580606 10.1159/000078498 (Pubitemid 38716259)
75. Jeon T. I., Park J. W., Ahn J., Jung C. H., Ha T. Y., Fisetin protects against hepatosteatosis in mice by inhibiting miR-378. Molecular Nutrition & Food Research 2013 57 11 1931 1937
76. Léotoing L., Wauquier F., Guicheux J., Miot-Noirault E., Wittrant Y., Coxam V., The polyphenol fisetin protects bone by repressing NF- B and MKP-1-dependent signaling pathways in osteoclasts. PLoS ONE 2013 8 7 2-s2.0-84879835492 10.1371/journal.pone.0068388 e68388
77. Prakash D., Gopinath K., Sudhandiran G., Fisetin enhances behavioral performances and attenuates reactive gliosis and inflammation during aluminum chloride-induced neurotoxicity. NeuroMolecular Medicine 2013 15 1 192 208 2-s2.0-84874703613 10.1007/s12017-012-8210-1
78. Prasath G. S., Sundaram C. S., Subramanian S. P., Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats. Endocrine 2013 44 2 359 368 2-s2.0-84871531061 10.1007/s12020-012-9866-x
79. Baker M. E., Medlock K. L., Sheehan D. M., Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proceedings of the Society for Experimental Biology and Medicine 1998 217 3 317 321 2-s2.0-0031936765
80. Sugihara N., Arakawa T., Ohnishi M., Furuno K., Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with α -linolenic acid. Free Radical Biology and Medicine 1999 27 11-12 1313 1323 2-s2.0-0033410209 10.1016/S0891-5849(99)00167-7 (Pubitemid 30001494)
81. Takano-Ishikawa Y., Goto M., Yamaki K., Inhibitory effects of several flavonoids on E-selectin expression on human umbilical vein endothelial cells stimulated by tumor necrosis factor- α Phytotherapy Research 2003 17 10 1224 1227 2-s2.0-0347987010 10.1002/ptr.1371 (Pubitemid 38057185)
82. Shimada H., Miura K., Imamura Y., Characteristics and inhibition by flavonoids of 20 α -hydroxysteroid dehydrogenase activity in mouse tissues. Life Sciences 2006 78 25 2931 2936 2-s2.0-33646179905 10.1016/j.lfs.2005.11.022
83. Park H.-H., Lee S., Son H.-Y., Park S.-B., Kim M.-S., Choi E.-J., Singh T. S. K., Ha J.-H., Lee M.-G., Kim J.-E., Hyun M. C., Kwon T. K., Kim Y. H., Kim S.-H., Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Archives of Pharmacal Research 2008 31 10 1303 1311 2-s2.0-55149102265 10.1007/s12272-001-2110-5
84. Devi M. A., Das N. P., In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2. Cancer Letters 1993 69 3 191 196 2-s2.0-0027300847 10.1016/0304-3835(93)90174-8 (Pubitemid 23182036)
85. Jin C.-H., Shin E.-J., Park J.-B., Jang C.-G., Li Z., Kim M. S., Koo K. H., Yoon H.-J., Park S.-J., Choi W.-C., Yamada K., Nabeshima T., Kim H.-C., Fustin flavonoid attenuates β -amyloid (1-42)-induced learning impairment. Journal of Neuroscience Research 2009 87 16 3658 3670 2-s2.0-71249123562 10.1002/jnr.22159
86. Westenburg H. E., Lee K.-J., Lee S. K., Fong H. H. S., Van Breemen R. B., Pezzuto J. M., Kinghorn A. D., Activity-guided isolation of antioxidative constituents of Cotinus coggygria. Journal of Natural Products 2000 63 12 1696 1698 2-s2.0-0034521397 10.1021/np000292h (Pubitemid 32038622)
87. Song M.-Y., Jeong G.-S., Kwon K.-B., Ka S.-O., Jang H.-Y., Park J.-W., Kim Y.-C., Park B.-H., Sulfuretin protects against cytokine-induced β -cell damage and prevents streptozotocin-induced diabetes. Experimental and Molecular Medicine 2010 42 9 628 638 2-s2.0-77957738989 10.3858/emm.2010.42.9.062
88. Song M.-Y., Jeong G.-S., Lee H.-S., Kwon K.-S., Lee S.-M., Park J.-W., Kim Y.-C., Park B.-H., Sulfuretin attenuates allergic airway inflammation in mice. Biochemical and Biophysical Research Communications 2010 400 1 83 88 2-s2.0-83655196239 10.1016/j.bbrc.2010.08.014
89. Lee K.-W., Chung K.-S., Seo J.-H., Yim S.-V., Park H.-J., Choi J.-H., Lee K.-T., Sulfuretin from heartwood of Rhus verniciflua triggers apoptosis through activation of Fas, Caspase-8, and the mitochondrial death pathway in HL-60 human leukemia cells. Journal of Cellular Biochemistry 2012 113 9 2835 2844 2-s2.0-84863696107 10.1002/jcb.24158
90. Lee Y.-R., Hwang J.-K., Koh H.-W., Jang K. Y., Lee J. H., Park J.-W., Park B.-H., Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice. Life Sciences 2012 90 19-20 799 807 2-s2.0-84860770445 10.1016/j.lfs.2012.04.015
91. Kim J.-M., Noh E.-M., Kwon K.-B., Kim J.-S., You Y.-O., Hwang J.-K., Hwang B.-M., Kim M. S., Lee S.-J., Jung S.-H., Youn H.-J., Chung E.-Y., Lee Y.-R., Suppression of TPA-induced tumor cell invasion by sulfuretin via inhibition of NF- B-dependent MMP-9 expression. Oncology Reports 2013 29 3 1231 1237 2-s2.0-84872803349 10.3892/or.2012.2218
92. Poudel S., Song J., Jin E.-J., Song K., Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines. Biochemical and Biophysical Research Communications 2013 431 3 572 578 2-s2.0-84873741062 10.1016/j.bbrc.2013.01.012
93. Richter M., Ebermann R., Marian B., Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutrition and Cancer 1999 34 1 88 99 2-s2.0-0032863640 (Pubitemid 29382921)
94. Fiander H., Schneider H., Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Letters 2000 156 2 117 124 2-s2.0-0034637704 10.1016/S0304-3835(00)00368-2 (Pubitemid 30394668)
95. Mastuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M., Structural requirements of flavonoids for inhibition of antigen-induced degranulation, TNF- α and IL-4 production from RBL-2H3 cells. Bioorganic and Medicinal Chemistry 2002 10 10 3123 3128 2-s2.0-0036340280 10.1016/S0968-0896(02)00227-4 (Pubitemid 34855385)
96. Hendriks J. J. A., De Vries H. E., Van Der Pol S. M. A., Van Den Berg T. K., Van Tol E. A. F., Dijkstra C. D., Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochemical Pharmacology 2003 65 5 877 885 2-s2.0-0037333185 10.1016/S0006-2952(02)01609-X (Pubitemid 36293703)
97. Monasterio A., Urdaci M. C., Pinchuk I. V., López-Moratalla N., Martínez-Irujo J. J., Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutrition and Cancer 2004 50 1 90 100 2-s2.0-9744225155 (Pubitemid 39587610)
98. Kim H., Park B.-S., Lee K.-G., Cheol Y. C., Sung S. J., Kim Y.-H., Lee S.-E., Effects of naturally occurring compounds on fibril formation and oxidative stress of β -amyloid. Journal of Agricultural and Food Chemistry 2005 53 22 8537 8541 2-s2.0-27744563958 10.1021/jf051985c (Pubitemid 41608910)
99. Won J. L., Shim J.-Y., Zhu B. T., Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Molecular Pharmacology 2005 68 4 1018 1030 2-s2.0-25144507259 10.1124/mol.104.008367 (Pubitemid 41345793)
100. Lyu S.-Y., Rhim J.-Y., Park W.-B., Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Archives of Pharmacal Research 2005 28 11 1293 1301 2-s2.0-28944454312 (Pubitemid 41781926)
101. Ichimatsu D., Nomura M., Nakamura S., Moritani S., Yokogawa K., Kobayashi S., Nishioka T., Miyamoto K.-I., Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 CI 41 cells. Molecular Carcinogenesis 2007 46 6 436 445 2-s2.0-34250191841 10.1002/mc.20292 (Pubitemid 46897048)
102. Lin C.-W., Hou W.-C., Shen S.-C., Juan S.-H., Ko C.-H., Wang L.-M., Chen Y.-C., Quercetin inhibition of tumor invasion via suppressing PKC δ /ERK/ AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008 29 9 1807 1815 2-s2.0-51849133195 10.1093/carcin/bgn162
103. Resende F. A., de Oliveira A. P., de Camargo M. S., Vilegas W., Varanda E. A., Evaluation of estrogenic potential of flavonoids using a recombinant yeast strain and MCF7/BUS cell proliferation assay. PLoS ONE 2013 8 10 e74881
104. Scartozzi M., Pistelli M., Bittoni A., Giampieri R., Galizia E., Berardi R., Faloppi L., Del Prete M., Cascinu S., Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy. Current Oncology Reports 2010 12 3 175 185 2-s2.0-77952240483 10.1007/s11912-010-0101-8
105. Azim J., de Azambuja E., Colozza M., Bines J., Piccart M. J., Long-term toxic effects of adjuvant chemotherapy in breast cancer. Annals of Oncology 2011 22 9 1939 1947 2-s2.0-79956131298 10.1093/annonc/mdq683
106. Cutuli B., Kanoun S., Tunon De Lara C., Baron M., Livi L., Levy C., Cohen-Solal-Lenir C., Lesur A., Kerbrat P., Provencio M., Gonzague-Casabianca L., Mege A., Lemanski C., Delva C., Lancrenon S., Velten M., Breast cancer occurred after Hodgkin's disease: clinico-pathological features, treatments and outcome: analysis of 214 cases. Critical Reviews in Oncology/Hematology 2012 81 1 29 37 2-s2.0-84855957459 10.1016/j.critrevonc.2011.01.005
107. Burris H. A. III, Moore M. J., Andersen J., Green M. R., Rothenberg M. L., Modiano M. R., Cripps M. C., Portenoy R. K., Storniolo A. M., Tarassoff P., Nelson R., Dorr F. A., Stephens C. D., Von Hoff D. D., Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology 1997 15 6 2403 2413 2-s2.0-8244254377 (Pubitemid 27251144)
108. Moore M. J., Goldstein D., Hamm J., Figer A., Hecht J. R., Gallinger S., Au H. J., Murawa P., Walde D., Wolff R. A., Campos D., Lim R., Ding K., Clark G., Voskoglou-Nomikos T., Ptasynski M., Parulekar W., Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology 2007 25 15 1960 1966 2-s2.0-34249933404 10.1200/JCO.2006.07.9525 (Pubitemid 46972777)
109. Cunningham D., Chau I., Stocken D. D., Valle J. W., Smith D., Steward W., Harper P. G., Dunn J., Tudur-Smith C., West J., Falk S., Crellin A., Adab F., Thompson J., Leonard P., Ostrowski J., Eatock M., Scheithauer W., Herrmann R., Neoptolemos J. P., Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. Journal of Clinical Oncology 2009 27 33 5513 5518 2-s2.0-73949135518 10.1200/JCO.2009.24.2446
110. Buckkingham J., Dictionary of Natural Products 1994 761 Chapman Hall
111. Yit C. C., Das N. P., Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Letters 1994 82 1 65 72 2-s2.0-0028336781 10.1016/0304-3835(94)90147-3 (Pubitemid 24211073)
112. Tilton B., Wilderness First Responder: How to Recognize, Treat, and Prevent Emergencies in the Backcountry 2004 Globe Pequot
113. Ehling D., Oriental medicine: an introduction. Alternative Therapies in Health and Medicine 2001 7 4 71 82 2-s2.0-0034936851 (Pubitemid 32625462)